GENESTITCH

What this means for you

Not registered yet, but its 15 Sept 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

99393442

Mark type

Stylized text

Filed

15 Sept 2025

Attorney of record

Christina M. Licursi

Goods and services

• Class 001 — Chemicals: Biological and chemical agents; small molecules for use in scientific research; bacterial and viral substances other than for medical and veterinary uses; chemicals and biological chemical preparations for use in medical science, namely, for use in biochemical and clinical research;
• Class 005 — Pharmaceuticals: Pharmaceutical preparations and therapeutics
• Class 042 — Scientific and technological services: scientific research and pharmaceutical development services; development of gene-based medicines; medical and scientific research in the fields of genetics, genomics, gene modulation and genetic engineering; DNA and RNA analysis and sequencing services for scientific and research purposes; research, development and scientific consultancy in the field of genomics and gene modulation; scientific research in the field of biology, molecular biology, cell biology, biotechnology, bacteriology, immunology, genetics, medicine, pharmacology, virology, chemistry, scientific research of vaccines, and antibiotics; software using artificial intelligence, computational methods, and machine learning models for data analysis in the fields of disease, biomedical, and genomic research; software using artificial intelligence, computational methods, and machine learning models for the design and characterization of therapeutic products and drug analysis in the field of drug discovery and development; software using artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, molecular, biochemical, and biomarker information, associations, conditions, outcomes, effects and risks

Owner

• Weaver Biosciences, Inc., Boston, MA, US

Prosecution history

• 19 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 19 Mar 2026 — NON-FINAL ACTION E-MAILED
• 19 Mar 2026 — NON-FINAL ACTION WRITTEN
• 18 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 18 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 18 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 09 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 09 Feb 2026 — NON-FINAL ACTION E-MAILED
• 09 Feb 2026 — NON-FINAL ACTION WRITTEN
• 09 Feb 2026 — ASSIGNED TO EXAMINER
• 06 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 15 Sept 2025 — APPLICATION FILING RECEIPT MAILED
• 15 Sept 2025 — NEW APPLICATION ENTERED